Jardiance (2020-09-14)
- Starting date:
- September 14, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-73947
Last updated:
2020-09-17
Summary
-
Product:
Jardiance
Reason
The affected lot is out of specification (OOS) for Uniformity of Dosage Units.
Depth of distribution
Wholesalers
Affected products
Jardiance
DIN, NPN, DIN-HIM
DIN 02443945
Dosage form
Tablet
Strength
Empagliflozin 25 MG
Lot or serial number
958266
Companies
- Recalling Firm
-
Boehringer Ingelheim (Canada) Ltd
5180 South Service Road
Burlington
L7L 5H4
Ontario
CANADA
- Marketing Authorization Holder
-
Boehringer Ingelheim (Canada) Ltd
5180 South Service Road
Burlington
L7L 5H4
Ontario
CANADA